These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Screening for gestational diabetes: an analysis of health benefits and costs. Everett WD Am J Prev Med; 1989; 5(1):38-43. PubMed ID: 2500963 [TBL] [Abstract][Full Text] [Related]
4. Should all pregnant women be screened for gestational glucose intolerance? Ales KL; Santini DL Lancet; 1989 May; 1(8648):1187-91. PubMed ID: 2566747 [TBL] [Abstract][Full Text] [Related]
5. Gestational diabetes guidelines in a HAPO world. Leary J; Pettitt DJ; Jovanovic L Best Pract Res Clin Endocrinol Metab; 2010 Aug; 24(4):673-85. PubMed ID: 20832745 [TBL] [Abstract][Full Text] [Related]
6. [Various glucose tolerance test (50 g, 75 g and 100 g) and diagnostic criteria of diabetics]. Nakagawa S; Aoki S Nihon Rinsho; 1990 Dec; 48 Suppl():546-52. PubMed ID: 2086932 [No Abstract] [Full Text] [Related]
8. Cost-effective criteria for glucose screening. Marquette GP; Klein VR; Repke JT; Niebyl JR Obstet Gynecol; 1985 Aug; 66(2):181-4. PubMed ID: 3927207 [TBL] [Abstract][Full Text] [Related]
9. [Screening for diabetes in obese pregnant women]. Szilágyi A; Feledi E; Csaba I; Pejtsik B Orv Hetil; 1990 Jul; 131(29):1585-8. PubMed ID: 2202945 [TBL] [Abstract][Full Text] [Related]
10. Diabetes and pregnancy: the public health perspective. Feldman J R I Med J (1976); 1989 Apr; 72(4):121-2. PubMed ID: 2727548 [No Abstract] [Full Text] [Related]
11. [Diabetes mellitus and pregnancy: screening and therapy]. Wunder D; Dürig P Praxis (Bern 1994); 2003 Mar; 92(13):591-6. PubMed ID: 12705182 [TBL] [Abstract][Full Text] [Related]
12. Cost-effective approach to office screening for gestational diabetes. Teplick FB; Lindenbaum CR; Cohen AW J Perinatol; 1990 Sep; 10(3):301-3. PubMed ID: 2120400 [TBL] [Abstract][Full Text] [Related]
13. [Screening studies in diagnosis of diabetes. Do they still have practical value?]. Ratzmann KP Fortschr Med; 1994 Apr; 112(11):150-3. PubMed ID: 8200597 [TBL] [Abstract][Full Text] [Related]
14. Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus. Lohse N; Marseille E; Kahn JG Int J Gynaecol Obstet; 2011 Nov; 115 Suppl 1():S20-5. PubMed ID: 22099435 [TBL] [Abstract][Full Text] [Related]
15. [A brief of gestational diabetes mellitus, risk factors and current criteria of diagnosis]. Al-Aissa Z; Hadarits O; Rosta K; Zóka A; Rigó J; Firneisz G; Somogyi A Orv Hetil; 2017 Feb; 158(8):283-290. PubMed ID: 28218564 [TBL] [Abstract][Full Text] [Related]
16. Serial changes in the 50-g oral glucose test in pregnancy: implications for screening. Watson WJ Obstet Gynecol; 1989 Jul; 74(1):40-3. PubMed ID: 2733939 [TBL] [Abstract][Full Text] [Related]
17. [Screening in the physicians practice for detection of diabetes mellitus and hyperlipoproteinemia]. Ratzmann KP Z Arztl Fortbild (Jena); 1993 Sep; 87(9):729-35. PubMed ID: 8237069 [No Abstract] [Full Text] [Related]
18. Role of screening tests for gestational carbohydrate intolerance. Mukherjee S; Sood M J Indian Med Assoc; 1994 Nov; 92(11):371-2. PubMed ID: 7890944 [TBL] [Abstract][Full Text] [Related]
19. [Clinical significance, diagnosis and treatment of diabetes in pregnancy (gestational diabetes)]. Berger W; Misteli F Ther Umsch; 1990 Jan; 47(1):71-9. PubMed ID: 2408184 [TBL] [Abstract][Full Text] [Related]
20. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]